Apollomics (APLMW) Competitors $0.0079 +0.00 (+1.28%) As of 03:49 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock APLMW vs. ATNFW, SXTPW, DRTSW, BCTXW, CDIOW, CELUW, CEROW, CINGW, CLNNW, and COEPWShould you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. Apollomics vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene Coeptis Therapeutics Apollomics (NASDAQ:APLMW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. Which has preferable earnings & valuation, APLMW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApollomicsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is APLMW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets ApollomicsN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media favor APLMW or ATNFW? In the previous week, 180 Life Sciences' average media sentiment score of 1.88 beat Apollomics' score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Apollomics Very Positive 180 Life Sciences Very Positive Summary180 Life Sciences beats Apollomics on 1 of the 1 factors compared between the two stocks. Get Apollomics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLMW vs. The Competition Export to ExcelMetricApollomicsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$221.25M$5.75B$9.77BDividend YieldN/A3.78%6.66%4.50%P/E RatioN/A40.2462.2622.40Price / SalesN/A5,238.69537.34111.77Price / CashN/A13.1925.7028.92Price / BookN/A82.9011.196.58Net IncomeN/A-$90.99M$3.28B$265.84M7 Day PerformanceN/A2.54%0.15%-0.07%1 Month PerformanceN/A17.06%8.34%5.83%1 Year PerformanceN/A483.53%54.21%17.88% Apollomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLMWApollomicsN/A$0.01+1.3%N/AN/A$0.00N/A0.0059Positive NewsGap DownHigh Trading VolumeATNFW180 Life SciencesN/A$0.32-15.8%N/A+2,100.5%$0.00N/A0.007Gap DownSXTPW60 Degrees PharmaceuticalsN/A$0.11-7.3%N/AN/A$0.00$641.41K0.002Positive NewsGap DownDRTSWAlpha Tau MedicalN/A$0.27flatN/AN/A$0.00N/A0.0080Positive NewsBCTXWBriaCell TherapeuticsN/A$0.02-16.0%N/A-90.7%$0.00N/A0.008Short Interest ↓Gap UpCDIOWCardio DiagnosticsN/A$0.01-6.3%N/AN/A$0.00$19.90K0.007Positive NewsShort Interest ↓CELUWCelularityN/A$0.04-30.1%N/A+201.5%$0.00$54.22M0.00220Positive NewsGap UpCEROWCERo TherapeuticsN/A$0.01-13.9%N/AN/A$0.00N/A0.008Positive NewsShort Interest ↓Gap DownCINGWCingulateN/A$0.05+0.4%N/AN/A$0.00N/A0.0020Positive NewsCLNNWCleneN/A$0.04+3.7%N/AN/A$0.00$286K0.00100Positive NewsCOEPWCoeptis TherapeuticsN/A$0.03+13.3%N/A+55.4%$0.00$62.87K0.004Gap Up Related Companies and Tools Related Companies ATNFW Alternatives SXTPW Alternatives DRTSW Alternatives BCTXW Alternatives CDIOW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives CLNNW Alternatives COEPW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLMW) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
